ED
AGNT

Exane Derivatives’s AGNT Inc AGNT Stock Holding History

Exane Derivatives’s Portfolio AGNT Stock Details AGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$953 Sell
81
-6,222
-99% -$90K ﹤0.01% 510
2022
Q1 		$133K Sell
6,303
-714
-10% -$18.7K 0.04% 428
2021
Q4 		$236K Buy
+7,017
New +$289K 0.06% 306

Other funds holding AGNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CRCM
Cat Rock Capital Management Greenwich, Connecticut $644M AUM 1.97% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Exane Derivatives's AGNT Position: Q2 2022 in Review

Exane Derivatives reduced its AGNT Inc (AGNT) stake by 99% in Q2 2022, selling an estimated $90K and leaving 81 shares worth $953. The position accounts for ﹤0.01% of the portfolio, ranked #510.

Exane Derivatives first reported a position in AGNT in Q4 2021 and has held it in 3 quarters since. The position peaked at $236K in Q4 2021. 219 funds tracked by Wall St. Rank hold AGNT as of Q2 2022.

  • Exane Derivatives held 81 shares of AGNT Inc worth $953 as of Q2 2022.
  • Exane Derivatives sold 6,222 AGNT Inc shares in Q2 2022, an estimated $90K.
  • AGNT Inc made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #510 holding.
  • Exane Derivatives first reported a position in AGNT Inc in Q4 2021 and has held it in 3 quarters since.
  • Exane Derivatives's AGNT Inc position peaked at $236K in Q4 2021.
  • 219 funds tracked by Wall St. Rank held AGNT Inc as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.